Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
Purpose. Systemic mastocytosis (SM) is characterized by a clonal proliferation of neoplastic mast cells (MCs) in one or more extracutaneous organs including the bone marrow (BM). SM is often associated with osteoporosis (OP) and fractures. Hypertryptasemia usually occurs in SM. We investigated the p...
Main Authors: | Giulia Carosi, Gregorio Guabello, Matteo Longhi, Federica Grifoni, Elena Passeri, Sabrina Corbetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/5785378 |
Similar Items
-
A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women
by: Elena Passeri, et al.
Published: (2015-01-01) -
Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity
by: C. Aresta, et al.
Published: (2019-01-01) -
Human Skin-Derived Mast Cells Spontaneously Secrete Several Angiogenesis-Related Factors
by: Cody McHale, et al.
Published: (2019-06-01) -
Balance Disorders in the Osteoporotic Elderly
by: Şule Şahin Onat, et al.
Published: (2013-12-01) -
Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women
by: Jacopo Antonino Vitale, et al.
Published: (2021-05-01)